research use only
Cat.No.S7158
|
In vitro |
Water : 100 mg/mL
DMSO
: 24 mg/mL
(39.82 mM)
Ethanol : 13 mg/mL The solubility data above are all experimental results (not literature values). |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
Read more about LY2835219 (Abemaciclib) Mesylate solubility in DMSO or water
Read more about LY2835219 (Abemaciclib) Mesylate working concentrations for cell culture treatment
LY2835219 (Abemaciclib) Mesylate is a potent inhibitor of HIPK2 (0.45 ±0.12 µM), CDK4/CyclinD3 (7.8 nM), CDK6/CyclinD3 (55.5 nM). LY2835219 (Abemaciclib) Mesylate exhibits the greatest inhibitory potency toward CDK4/CyclinD3 (IC50 = 7.8 nM).
| Information | LY2835219 (Abemaciclib) Mesylate is a potent, selective, and reversible ATP-competitive CDK4/6 inhibitor. It affects Rb/E2F signaling by blocking retinoblastoma protein phosphorylation, effectively inhibiting G1 to S phase cell cycle progression and tumor cell proliferation. |
|---|---|
|
Read more about LY2835219 (Abemaciclib) Mesylate IC50 for cell-based and cell-free assays |
|
| Primary Applications and Mechanism of Action | |
Read more about LY2835219 (Abemaciclib) Mesylate Mechanism of Action
| Molecular Weight | 602.7 | Formula | C27H32F2N8.CH4O3S |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 1231930-82-7 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | LY2835219 mesylate | Smiles | CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F.CS(=O)(=O)O | ||
Read more comparative analysis about LY2835219 (Abemaciclib) Mesylate
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Question 1:
Is your product S7158 “mesylate salt form”?
Answer:
It is the mesylate salt form of our S7158 LY2835219.